Patents Assigned to Olfactive Biosolutions, LLC
  • Compositions and methods for treating hypertension by modulating endocrine activity
    Patent number: 12186299
    Abstract: Disclosed herein are compounds and ligands, and compositions formed therewith, that modulate seminal endocrine factors that control blood pressure and, thereby, treat hypertension. Also disclosed herein are methods for using the compositions to treat hypertension and disorders associated therewith.
    Type: Grant
    Filed: August 21, 2024
    Date of Patent: January 7, 2025
    Assignee: Olfactive Biosolutions, LLC
    Inventors: Christopher Hanson, William Harries
  • Compositions and methods for treating endocrine diseases and disorders
    Patent number: 12171727
    Abstract: Disclosed herein are compounds and ligands, and compositions formed therewith, that modulate insulin secretion and suppress appetite by activating ectopic olfactory receptors. Also disclosed herein are methods for using the compositions to treat endocrine diseases, such as type-2 diabetes, and disorders, such as abnormal insulin secretion.
    Type: Grant
    Filed: August 19, 2024
    Date of Patent: December 24, 2024
    Assignee: Olfactive Biosolutions, LLC
    Inventors: Christopher Hanson, William Harries
  • Compositions and methods for treating endocrine diseases and disorders
    Patent number: 12115134
    Abstract: Disclosed herein are compounds and ligands, and compositions formed therewith, that modulate insulin secretion and suppress appetite by activating ectopic olfactory receptors. Also disclosed herein are methods for using the compositions to treat endocrine diseases, such as type-2 diabetes, and disorders, such as abnormal insulin secretion.
    Type: Grant
    Filed: February 2, 2024
    Date of Patent: October 15, 2024
    Assignee: Olfactive Biosolutions, LLC
    Inventors: Christopher Hanson, William Harries
  • Compositions and methods for treating endocrine diseases and disorders
    Patent number: 12102664
    Abstract: Disclosed herein are compounds and ligands, and compositions formed therewith, that modulate insulin secretion and suppress appetite by activating ectopic olfactory receptors. Also disclosed herein are methods for using the compositions to treat endocrine diseases, such as type-2 diabetes, and disorders, such as abnormal insulin secretion.
    Type: Grant
    Filed: March 25, 2024
    Date of Patent: October 1, 2024
    Assignee: Olfactive Biosolutions, LLC
    Inventors: Christopher Hanson, William Harries
  • Compositions and methods for treating hypertension by modulating endocrine activity
    Patent number: 12102611
    Abstract: Disclosed herein are compounds and ligands, and antihypertensive compositions formed therewith, that modulate seminal endocrine factors that control blood pressure and, thereby, treat hypertension. Also disclosed herein are methods for using the antihypertensive compositions to treat hypertension and disorders associated therewith.
    Type: Grant
    Filed: March 25, 2024
    Date of Patent: October 1, 2024
    Assignee: Olfactive Biosolutions, LLC
    Inventors: Christopher Hanson, William Harries